Sclerotioloids A–C: Three New Alkaloids from the Marine-Derived Fungus Aspergillus sclerotiorum ST0501
Marine Drugs · 2023
DOI: 10.3390/md21040219 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Jun-Qiu Mao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, The Ministry of Education of China, Institute of Evolution & Marine Biodiversity, School of Medicine and Pharmacy, Oc…. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Alkaloids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shandong Provincial Natural Science Foundation (Major Basic Research Projects), Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Alkaloids, as one of the largest classes of natural products with diverse structures, are an important source of innovative medicines. Filamentous fungi, especially those derived from the marine environment, are one of the major producers of alkaloids. In this study, three new alkaloids, sclerotioloids A–C (1–3), along with six known analogs (4–9), were obtained under the guidance of the MS/MS-based molecular networking from the marine-derived fungus, Aspergillus sclerotiorum ST0501, collected from the South China Sea. Their chemical structures were elucidated by comprehensive analysis of the spectroscopic data, including 1D and 2D NMR and HRESIMS. Additionally, the configuration of compound 2 was unambiguously determined by X-ray single crystal diffraction, and that of compound 3 was determined by the TDDFT-ECD approach. Sclerotioloid A (1) represents the first example of 2,5-diketopiperazine alkaloid with a rare terminal alkyne. Sclerotioloid B (2) showed the inhibition of NO production induced by lipopolysaccharide (LPS), with an inhibition rate of 28.92% higher than that of dexamethasone (25.87%). These results expanded the library of fungal-derived alkaloids and further prove the potential of marine fungi in the generation of alkaloids with new scaffolds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, The Ministry of Education of China, Institute of Evolution & Marine Biodiversity, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
- Fujian Key Laboratory on Conservation and Sustainable Utilization of Marine Biodiversity, Institute of Oceanography, Minjiang University, Fuzhou 350108, China.
- Laboratory for Marine Drugs and Bioproducts, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China.
- Institute for Insect Biotechnology, Justus-Liebig-University of Giessen, 35392 Giessen, Germany.
- Department of Bioresources of the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), 35392 Giessen, Germany.
Förderung
- National Natural Science Foundation of China
- Shandong Provincial Natural Science Foundation (Major Basic Research Projects)
- Natural Science Foundation of Fujian Province
- Minjiang University
- Program of Open Studio for Druggability Research of Marine Natural Products
- National Laboratory for Marine Science and Technology
- Taishan Scholars Program
Zitieren
APA
Mao, J. Q., Zheng, Y. Y., Wang, C. Y., Liu, Y., & Yao, G. S. (2023). Sclerotioloids A–C: Three New Alkaloids from the Marine-Derived Fungus Aspergillus sclerotiorum ST0501. Marine Drugs. https://doi.org/10.3390/md21040219
Vancouver
Mao JQ, Zheng YY, Wang CY, Liu Y, Yao GS. Sclerotioloids A–C: Three New Alkaloids from the Marine-Derived Fungus Aspergillus sclerotiorum ST0501. Marine Drugs. 2023. doi:10.3390/md21040219
BibTeX
@article{Mao2023,
author = {Mao, Jun-Qiu and Zheng, Yao-Yao and Wang, Chang-Yun and Liu, Yang and Yao, Guang-Shan},
title = {Sclerotioloids A–C: Three New Alkaloids from the Marine-Derived Fungus Aspergillus sclerotiorum ST0501},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21040219}
}
EUVIMED